Diagnosis of unknown primary cancer based on molecular techniques may influence therapeutic approach and improve survival

ABSTRACT

Unknown primary cancer (UPC) is a common clinical syndrome classically associated with a poor prognosis. Pathological examination including immunohistochemistry continues to be essential in tumour origin characterization, although in many cases primary tumour site remains unknown. Gene expression based analysis may offer important diagnostic information that could lead to therapeutic decisions (AU)